Roy D. Baynes - 12 Feb 2025 Form 3 Insider Report for Aardvark Therapeutics, Inc. (AARD)

Role
Director
Signature
/s/ Nelson Sun, as Attorney-in-Fact
Issuer symbol
AARD
Transactions as of
12 Feb 2025
Transactions value $
$0
Form type
3
Filing time
12 Feb 2025, 19:19:43 UTC
Previous filing
10 Feb 2025
Next filing
13 Mar 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding AARD Stock Option (Right to Buy) 12 Feb 2025 Common Stock 29,502 $7.04 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the original number of shares subject to the option shall vest on December 18, 2025, and 1/48th of the original number of shares subject to the option shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service through each vesting date, inclusive.

Remarks:

Exhibit 24 - Power of Attorney